Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.

导出 OA

翻译打印收藏纠错

作者： Renato D,Lopes ^[1] ; Ariane Vieira Scarlatelli,Macedo ^[2] ; Pedro Gabriel Melo,de Barros E Silva ^[3] ; Renata Junqueira,Moll-Bernardes ^[4] ; Andre,Feldman ^[5] ; Guilherme,D'Andréa Saba Arruda ^[5] ; Andrea Silvestre,de Souza ^[6] ; Denilson Campos,de Albuquerque ^[7] ; Lilian,Mazza ^[3] ; Mayara Fraga,Santos ^[4] ; Natalia Zerbinatti,Salvador ^[4] ; C Michael,Gibson ^[8] ; Christopher B,Granger ^[9] ; John H,Alexander ^[9] ; Olga Ferreira,de Souza ^[5] ; BRACE CORONA investigators

作者单位： D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Brazilian Clinical Research Institute, São Paulo, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil. Electronic address: renato.lopes@dm.duke.edu. ^[1] D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil; Santa Casa de São Paulo, São Paulo, Brazil. ^[2] Brazilian Clinical Research Institute, São Paulo, Brazil. ^[3] D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil. ^[4] D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Rede D'Or São Luiz (RDSL), São Paulo, Brazil. ^[5] D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. ^[6] D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil. ^[7] Harvard Medical School, Boston, MA, USA. ^[8] Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. ^[9]

主题词血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);巴西(Brazil);临床试验, Ⅳ期(主题)(Clinical Trials, Phase IV as Topic);冠状病毒感染(Coronavirus Infections);人类(Humans);住院病人(Inpatients);多中心研究(主题)(Multicenter Studies as Topic);疾病大流行(Pandemics);肽基二肽酶A(Peptidyl-Dipeptidase A);肺炎, 病毒性(Pneumonia, Viral);随机对照试验(主题)(Randomized Controlled Trials as Topic);肾素-血管紧张素系统(Renin-Angiotensin System);病毒整合(Virus Integration);停止治疗(Withholding Treatment)

DOI 10.1016/j.ahj.2020.05.002

PMID 32502882

发布时间 2024-07-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American heart journal

2020年226卷

49-59页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.

American heart journal

相似文献

American heart journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.

American heart journal

相似文献

American heart journal

相关期刊

检索历史清除